Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,949.0
-24.5 (-0.82%)

 

  • STI Straits Times Index
    2,949.0
    -24.5 (-0.82%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,577.8
    -3.8 (-0.24%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,980.2
    -1,094.0 (-3.64%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,509.1
    -76.0 (-2.12%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    -
    -
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,241.8
    -47.8 (-0.76%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,281.1M
  • Value: 2,309.6M
  • Rise: 109
  • Fall: 262
  • Unch: 403

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
CWX Global0.007+0.002
Thomson Medical0.119-
Oceanus^0.071-0.004
Jiutian Chemical0.089-0.006
SPH1.400+0.120
Secura0.102-0.001
YZJ Shipbldg SGD1.070+0.010
Sembcorp Marine0.153-0.002
Anchor Resources0.015-
ThaiBev0.735-

World Indices

World Indices
Name Last Change
Nasdaq 13,192.3 +72.9
HSI 28,980.2 -1094.0
HSCEI 11,247.2 -470.2
Jakarta 6,241.8 -47.9
Nikkei 225 0.0
SSE Comp 3,509.1 -76.0
Shanghai A 3,678.3 -79.7
Shanghai B 243.4 -2.6
KOSPI 3,012.9 -86.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 26 Feb 2021 17:13
Last (SGD): 1.100 Change: -0.010 High: 1.130 Remarks: -
Change (%): -0.90 Low: 1.090
Open 1.100 Yesterday's Close 1.110
Buy Price 1.100 Sell Price 1.110
Buy Volume ('000) 116.1 Sell Volume ('000) 346.3
Cumulative Volume ('000) 10,823.8 Cumulative Value 11,917,090
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.00285 Trailing EPS (SGD) e 0.10052 NAV (SGD) b 0.2571
PE a 385.965 Trailing PE f 10.943 Price / NAV b 4.2785
Dividend (SGD) d - Cash In Hand (SGD) g 0.0525 Issued & Paid-up Shares c 549,411,000
Dividend Yield (%) d - Price / Cash In Hand g 20.952 Treasury Shares h -
Beta - 75 Daysi -0.547 R-Squared - 75 Days(%)i 1.13 Market Cap (M) 604.352
Beta - 500 Daysi -0.160 R-Squared - 500 Days (%)i 0.04 Enterprise Value (M) 632.055
Piotroski F Score 7 Exchange Code 546 Par Value ( USD ) 0.05000
52 Weeks Volatility (%) 132.9759 6-Month VWAP 1.162 Free Float (%) 99.7
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 23 Dec 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 604.352 385.965 10.943 4.2785 -
Industry Medical & Biotechnology SGX 954.788 20.766 21.877 1.3785 1.998
Medical Specialties SGX 2,572.407 25.161 10.513 7.1720 2.038
Index FTSE ST Catalist Index SGX 57.765 30.063 88.683 1.3442 1.221
Local Peer Top Glove SGX 14,321.783 23.590 10.598 7.8681 2.186
Local Peer UGHealthcare SGX 397.487 29.655 5.889 3.1295 0.352
Local Peer Biolidics SGX 77.894 - - 7.2304 -
Local Peer Annica SGX 16.675 - - 5.0000 -
Local Peer Yunnan Energy SGX 16.251 - - 0.3360 -
Global Peer ABBOTT LABORATORIES NYSE 212,193.863 47.439 47.439 6.4725 1.277
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 177,238.353 27.802 27.802 5.1363 0.197
Global Peer MEDTRONIC PLC NYSE 157,613.566 32.912 54.500 3.1052 1.906
Global Peer DANAHER CORP NYSE 156,449.853 44.573 44.573 4.2865 0.327
Global Peer STRYKER CORP NYSE 91,300.221 57.098 57.098 6.9780 0.970
Global Peer INTUITIVE SURGICAL INC NASDAQ 86,734.622 81.779 81.779 8.9128 -
Global Peer BECTON DICKINSON & CO NYSE 70,068.544 91.354 46.465 2.8413 1.324
Global Peer BOSTON SCIENTIFIC CORP NYSE 54,957.853 - - 3.5857 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 51,897.529 63.029 63.028 11.3455 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 49,561.283 36.321 36.321 3.4125 1.887
Other Global Peers ALIGN TECHNOLOGY INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), BAXTER INTERNATIONAL INC (NYSE), DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), TELEFLEX INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), NOVOCURE LTD (NASDAQ), STERIS PLC (NYSE), ABIOMED INC (NASDAQ), PERKINELMER INC (NYSE), MASIMO CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), DENTSPLY SIRONA INC (NASDAQ), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), MICROPORT (HKEx), TOPGLOV (Bursa), PENUMBRA INC (NYSE), BRUKER CORPORATION (NASDAQ), HARTA (Bursa), WEIGAO GROUP (HKEx), SOTERA HEALTH CO (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), QUIDEL CORP (NASDAQ), HAEMONETICS CORP (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), TANDEM DIABETES CARE INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEVRO CORP (NYSE), CARDIOFLOW-B (HKEx), INARI MEDICAL INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), ICU MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), GLAUKOS CORPORATION (NYSE), CAREDX INC (NASDAQ), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), VENUS MEDTECH-B (HKEx), LIVANOVA PLC (NASDAQ), BUTTERFLY NETWORK INC (NYSE), CONMED CORP (NYSE), EBOS GROUP (ASX), CANTEL MEDICAL CORP (NYSE), NUVASIVE INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), SUPERMX (Bursa), ATRICURE INC (NASDAQ), INMODE LTD (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), EARGO INC (NASDAQ), VERICEL CORP (NASDAQ), AVANOS MEDICAL INC (NYSE), LIFETECH SCI (HKEx), OUTSET MEDICAL INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), PEIJIA-B (HKEx), PULMONX CORPORATION (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), HESKA CORP (NASDAQ), KANGJI MEDICAL (HKEx), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), AK MEDICAL (HKEx), ESTABLISHMENT LABS HLDGS INC (NASDAQ), DERMTECH INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), NANOSONICS LIMITED (ASX), MESA LABORATORIES INC (NASDAQ), 908 DEVICES INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), INOGEN INC (NASDAQ), ATRION CORP (NASDAQ), CIRC (HKEx), CELLDEX THERAPEUTICS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), CERUS CORP (NASDAQ), SI BONE INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CRYOLIFE INC (NYSE), TRANSMEDICS GROUP INC (NASDAQ), BASECARE-B (HKEx), ORTHOFIX MEDICAL INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), AXOGEN INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CHUNLI MEDICAL (HKEx), KDL MEDICAL (HKEx), ANGIODYNAMICS INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), SURMODICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), VIEWRAY INC (NASDAQ), BIOVENTUS INC (NASDAQ), VAPOTHERM INC (NYSE), CUTERA INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), STEREOTAXIS INC (NYSE American), ZYNEX INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), CORMEDIX INC (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ACCURAY INCORPORATED (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), QUOTIENT LTD (NASDAQ), PROFOUND MED CORP (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), MEDAVAIL HOLDINGS INC (NASDAQ), SIENTRA INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), NEURONETICS INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), YESTAR HEALTH (HKEx), CLEANSPACE HOLDINGS LTD (ASX), PAVMED INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), INVACARE CORP (NYSE), MEDICAL DEVELOPMENT INTL (ASX), UTAH MEDICAL PRODUCTS (NASDAQ), MISONIX INC (NASDAQ), SOLITON INC (NASDAQ), AROA BIOSURGERY LTD (ASX), IRADIMED CORP (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), DARIOHEALTH CORP (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), TELA BIO INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), ALPHA PRO TECH (NYSE American), INTRICOM CORP (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), CYCLOPHARM LIMITED (ASX), MODERN DENTAL (HKEx), CONFORMIS INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), REPRO MEDSYSTEMS INC (NASDAQ), ONCOCYTE CORP (NYSE American), AVINGER INC (NASDAQ), KELFRED (HKEx), VINCENT MED (HKEx), NEMAURA MEDICAL INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), VENUS CONCEPT INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), FONAR CORP (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MICRO-X LTD (ASX), BIOLASE INC (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), PW MEDTECH (HKEx), ZOSANO PHARMA CORP (NASDAQ), CELSION CORPORATION (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), ROCKWELL MEDICAL INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), IMPEDIMED LIMITED (ASX), SOMNOMED LIMITED (ASX), OPTISCAN IMAGING (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), VOLITIONRX LIMITED (NYSE American), LIANLUO SMART LIMITED (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROCORE INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), LENSAR INC (NASDAQ), NEOVASC INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ELECTROMED INC (NYSE American), APPLIED UV INC (NASDAQ), IRIDEX CORP (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), NEPHROS INC (NASDAQ), IMMUCELL CORP (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), YUNNAN ENERGY (HKEx), RGTBHD (Bursa), SDI LTD (ASX), BIOMERICA INC (NASDAQ), LKL (Bursa), RESPIRI LTD (ASX), RESONANCE HEALTH LTD (ASX), CANCER GENETICS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), CARDIEX LTD (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), COMPUMEDICS (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), DAXOR CORP (NYSE American), MOTUS GI HOLDINGS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), DIMERIX LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), RESAPP HEALTH LIMITED (ASX), TENAX THERAPEUTICS INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), AKERS BIOSCIENCES INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), LIFE HEALTHCARE (HKEx), CYANOTECH CORP (NASDAQ), TRUSCREEN GROUP LTD (ASX), DYNATRONICS CORP (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), CHF SOLUTIONS INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), USCOM LTD (ASX), METALICITY LIMITED (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), ADHERIUM LIMITED (ASX), DORSAVI LTD (ASX), ANALYTICA (ASX), INSPIREMD INC (NYSE American), HUAKANG BIOMED (HKEx), MEDIGARD LIMITED (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.030
-2.65 %
10 Days -+0.070
+6.80 %
20 Days -+0.060
+5.77 %
Medium Term Return 3 Months -+0.130
+13.40 %
6 Months 0.012-0.420
-26.84 %
1 Year 0.012+1.007
+1095.70 %
Long Term Return 2 Years 0.012+1.072
+3871.43 %
3 Years 0.012+1.054
+2317.39 %
5 Years 0.012+1.054
+2317.39 %
Annualised Return Annualised --
+89.09 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.055 - 1.980 Change From 1 Year Low +1.045 % Change From 1 Year Low (%) +1900.00
Change From 1 Year High -0.880 % Change From 1 Year High (%) -44.44
2 Years Range 0.022 - 1.980 Change From 2 Years Low +1.078 % Change From 2 Years Low (%) +4900.00
Change From 2 Years High -0.880 % Change From 2 Years High (%) -44.44
5 Years Range 0.022 - 1.980 Change From 5 Years Low +1.078 % Change From 5 Years Low (%) +4900.00
Change From 5 Years High -0.880 % Change From 5 Years High (%) -44.44
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

IPO Performance

Listing Date 06 Oct 1999 Full Subscription Rate (x) 10.99
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 18.00 Public Offer Subscription Rate (x) 25.98
IPO Price (SGD) a 0.251 First Day Close (SGD) a 0.334 First Week Close (SGD) a 0.328
Current vs IPO Price (%) +338.25 First Day Gain (%) +33.07 First Week Gain (%) +30.68
Notes:
  1. Adjusted for the following: Bonus issue 1 for 5 on 29/04/2004

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(5.04 MB)
Annual Report 2018 Dec 2018 Part 1(3.96 MB)
Annual Report 2017 Dec 2017 Part 1(3.57 MB)
Part 2(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(2.67 MB)
Annual Report 2015 Dec 2015 Part 1(1.52 MB)
Annual Report 2014 Dec 2014 Part 1(4.00 MB)
Annual Report 2013 Dec 2013 Part 1(3.85 MB)
Annual Report 2012 Dec 2012 Part 1(3.68 MB)
Annual Report 2011 Dec 2011 Part 1(6.92 MB)
Annual Report 2010 Dec 2010 Part 1(3.56 MB)
Annual Report 2009 Dec 2009 Part 1(2.70 MB)
Annual Report 2008 Dec 2008 Part 1(1.48 MB)
Annual Report 2007 Dec 2007 Part 1(3.26 MB)
Part 2(0.02 MB)
Annual Report 2006 Dec 2006 Part 1(7.72 MB)
Annual Report 2005 Dec 2005 Part 1(23.76 MB)
IPO Prospectus
IPO Prospectus 1999 Oct 1999 Part 1(0.12 MB)
Part 2(0.39 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
26 Feb 2021 1.100 1.130 1.090 1.100 10,823,800 1.1010
25 Feb 2021 1.120 1.140 1.110 1.110 6,222,200 1.1179
24 Feb 2021 1.140 1.140 1.100 1.120 8,821,200 1.1177
23 Feb 2021 1.150 1.160 1.130 1.140 5,645,300 1.1423
22 Feb 2021 1.130 1.170 1.110 1.130 11,036,800 1.1435
19 Feb 2021 1.160 1.170 1.100 1.130 12,573,100 1.1324
18 Feb 2021 1.050 1.140 1.040 1.140 14,590,300 1.0858
17 Feb 2021 1.050 1.060 1.040 1.040 2,691,400 1.0461
16 Feb 2021 1.050 1.050 1.030 1.050 2,762,900 1.0432
15 Feb 2021 1.040 1.060 1.040 1.040 4,246,200 1.0464
11 Feb 2021 1.040 1.040 1.020 1.030 3,175,000 1.0302
10 Feb 2021 1.030 1.050 1.030 1.030 3,205,900 1.0363
09 Feb 2021 1.040 1.060 1.030 1.030 4,686,200 1.0390
08 Feb 2021 1.080 1.080 1.040 1.040 5,631,200 1.0554
05 Feb 2021 1.100 1.110 1.070 1.070 7,713,200 1.0870
04 Feb 2021 1.070 1.100 1.070 1.080 8,824,600 1.0841
03 Feb 2021 1.060 1.080 1.050 1.060 7,754,800 1.0674
02 Feb 2021 1.060 1.080 1.050 1.060 6,364,800 1.0614
01 Feb 2021 1.050 1.060 1.040 1.050 5,624,700 1.0499
29 Jan 2021 1.040 1.090 1.030 1.040 9,320,000 1.0599
28 Jan 2021 1.060 1.070 1.020 1.020 7,169,300 1.0414
27 Jan 2021 1.100 1.120 1.060 1.060 9,016,400 1.0811
Summary
Current 2 Weeks
(15 Feb 2021 to 26 Feb 2021)
1.040 1.170 1.030 1.100 79,413,200 -
Previous 2 Weeks
(29 Jan 2021 to 11 Feb 2021)
1.040 1.170 1.030 1.030 62,300,400 -
4 Weeks from
(31 Dec 2020 to 28 Jan 2021)
1.010 1.170 1.000 1.020 182,110,700 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.